A detailed history of Bridgeway Capital Management, LLC transactions in Cortexyme, Inc. stock. As of the latest transaction made, Bridgeway Capital Management, LLC holds 128,617 shares of CRTX stock, worth $165,915. This represents 0.0% of its overall portfolio holdings.

Number of Shares
128,617
Previous 106,417 20.86%
Holding current value
$165,915
Previous $137,000 20.44%
% of portfolio
0.0%
Previous 0.0%

Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Aug 14, 2025

BUY
N/A
22,200 Added 20.86%
128,617 $165,000
Q1 2025

May 15, 2025

BUY
N/A
14,100 Added 15.27%
106,417 $137,000
Q4 2024

Feb 14, 2025

BUY
N/A
3,822 Added 4.32%
92,317 $119,000
Q3 2024

Nov 14, 2024

SELL
N/A
-50,000 Reduced 36.1%
88,495 $114,000
Q3 2023

Nov 14, 2023

BUY
N/A
83,495 Added 151.81%
138,495 $178,000
Q2 2023

Aug 14, 2023

SELL
N/A
-55,000 Reduced 50.0%
55,000 $70,000
Q3 2022

Nov 14, 2022

BUY
$1.29 - $2.52 $141,900 - $277,200
110,000 New
110,000 $146,000

Others Institutions Holding CRTX

About Cortexyme, Inc.


  • Ticker CRTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 36,150,800
  • Market Cap $70.5M
More about CRTX
Track This Portfolio

Track Bridgeway Capital Management, LLC Portfolio

Follow Bridgeway Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bridgeway Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Bridgeway Capital Management, LLC with notifications on news.